Surgery coverage typically starts at BMI 35, while semaglutide coverage often begins at BMI 27 with related health conditions
Higher doses bring higher side effect potential without guaranteed proportional benefit
Ozempic has been shown to have long-term effectiveness in managing blood sugar and promoting weight loss when combined with diet and exercise
Of the 14 semaglutide-treated patients that developed anti-semaglutide antibodies, 7 patients (0.2% of the overall population) developed antibodies cross-reacting with native GLP-1
This groundbreaking option eliminates the barrier of needle anxiety, offering a convenient, non-invasive way to effectively regulate appetite and improve metabolic health alongside diet and exercise
However, once patients stop taking semaglutide, many of them regain almost all of the body weight they initially lost